Previous studies have reported decreased levels of serum markers of intestinal integrity—such as diamine oxidase (DAO), d-lactic acid (D-LA), intestinal fatty acid-binding protein (I-FABP), and endothelin (ET)—in patients with insomnia, suggesting a potential barrier damage (Cai et al., 2024). The gene discussed is FABP2; the disease is insomnia measurement.